AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03851458 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Thrice weekly diet and exercise text messages (N vs. Y)
Description: Text message interventions have been demonstrated to be effective in increasing self-eﬃcacy, weight loss, and PA.65-67 Participants will receive thrice weekly healthy eating, PA, and health care access text message tips. Links to additional information and videos will also be sent via text (e.g. local farmers markets, healthy recipes, free exercise classes, workout videos, video demonstrations of how to prepare healthy meals, etc.). Texts were developed and piloted in the COMIDA Pilot, are designed to promote goal-setting, problem-solving, self-monitoring, modeling, and self-eﬃcacy, and will be further reﬁned during the formative research phase (see below). Texts will be sent via Mosio Text Messaging Solutions. Messages will be concise, as longer messages have shown no demonstrable impact. Based on each participant's status at intake, tailored text messages will also encourage regular follow-up with PCPs. Text messages will be interactive.
Study NCT03851458 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Weekly telephone support (N vs. Y)
Description: Several lifestyle interventions including Hispanics have successfully incorporated telephone support.134-138 Weekly telephone support (or more frequently if requested) will be delivered by the promotoras throughout the 6-month intervention. Frequent and prolonged contact in behavioral interventions is more effective than single sessions; most interventions leading to diet or PA changes persisting for >12 months have follow-up contact sessions for at least 4 months.18 Greater numbers of follow-up sessions facilitate success of behavior change, and initial behavior change can decrease with decreased contact.18,139 Telephone sessions (10-15 minutes) will use MI principles, will focus on goal-setting, problem solving, reviewing/integrating new diet/PA knowledge/skills (including self-monitoring) into individuals' daily routines, self-eﬃcacy enhancements, encouraging participants to seek opportunities for modeling and encouraging regular follow-up with PCPs.
Study NCT03851458 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-monitoring tools (N vs. Y) (for diet and weight)
Description: Self-monitoring is an important component in achieving behavioral change.18 Participants will be given a SANOS food diary (adapted for and pilot-tested at the VDS in our pilot work) and a digital scale. As part of VDS Mobile usual care, all participants will receive a pedometer to assess exercise behavior (secondary outcome), so additional self-monitoring tools for PA will not be included in this component.
Study NCT01633918 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-supported FeetEnergy approach
Description: Three health education lessons and two homework's about increasing physical activity and reducing screen time
Study NCT01633918 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual health education
Description: Usual health education lessons
Study NCT01445444 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Habit Reversal Training
Description: * 8 weekly therapy sessions lasting 50 minutes based on the protocol outlined by Woods (2001).~* The overall focus of treatment is to provide patients with tools to help them manage and reduce hair-pulling.~* components:~* Session 1. (a) to develop an understanding of the subject's hair-pulling through an initial interview; and (b) to establish a protocol for ongoing assessment.~* Session 2. implement habit reversal, including awareness training, competing response training, and social support.~* Sessions 3-8. For subjects with a single hair-pulling site, Session 3 will review and practice HRT procedures and name solutions to problems that may have arisen. For those with multiple hair-pulling sites, treatment will be reviewed for the first site in the hierarchy.
Study NCT01445444 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Habit Reversal Training
Description: * 8 weekly therapy sessions lasting 50 minutes based on the protocol outlined by Woods (2001).~* The overall focus of treatment is to provide patients with tools to help them manage and reduce hair-pulling.~* components:~* Session 1. (a) to develop an understanding of the subject's hair-pulling through an initial interview; and (b) to establish a protocol for ongoing assessment.~* Session 2. implement habit reversal, including awareness training, competing response training, and social support.~* Sessions 3-8. For subjects with a single hair-pulling site, Session 3 will review and practice HRT procedures and name solutions to problems that may have arisen. For those with multiple hair-pulling sites, treatment will be reviewed for the first site in the hierarchy.
Study NCT04481412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical cetirizine
Description: Topical cetirizine 1% spray that will be prepared at Faculty of Pharmacy, Cairo University and will be applied once daily.
Study NCT04481412 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: 96% ethanol that will be applied once daily.
Study NCT04481412 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topical minoxidil
Description: Topical Minoxidil 5% that will be applied once daily.
Study NCT04481412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical minoxidil
Description: Topical Minoxidil 5% that will be applied once daily.
Study NCT01349426 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: LigaSure Force Triad Vessel Sealing System
Description: Quality of parenchymal pneumostasis comparison after fissure closure: LigaSure vs automatic staplers
Study NCT01349426 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LigaSure Force Triad Vessel Sealing System
Description: Quality of parenchymal pneumostasis comparison after fissure closure: LigaSure vs automatic staplers
Study NCT03397979 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Infrequent versus Frequent Soaking Baths
Description: Submersion of skin, affected by atopic dermatitis, in a bathtub filled with luke-warm water, where the frequency and duration of these baths are varied, to look for any differential effect.
Study NCT02832648 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: selenase (selenium)
Description: Selenase (Biosyn, Germany) Sodium selenite pentahydrate
Study NCT02832648 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: selenase (selenium)
Description: Selenase (Biosyn, Germany) Sodium selenite pentahydrate
Study NCT03164668 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: menthol flavored e-cigarette
Description: menthol flavored e-cigarette
Study NCT03164668 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: tobacco flavored e-cigarette
Description: tobacco flavored e-cigarette
Study NCT02251262 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Whole-body 18FDG-PET-CT scan
Description: 18FDG-PET-CT exam will be performed in patients, with suspicion of pacing or defibrillation lead infection, hospitalized in cardiology unit.
Study NCT03732573 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text messages
Description: Text messages conveying 3 specific behaviour change techniques
Study NCT01032616 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Threonine Experimental: Study Period 1
Description: Enteral and parenteral infusion of threonine isotope
Study NCT01032616 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lysine Experimental: Study Period 2
Description: Both intravenous (iv) and intragastric (ig) Lysine isotopes.
Study NCT02517918 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sirolimus combined with CP, MT and ZA
Description: Cyclophosphamide, Methotrexate and Sirolimus will be administrated orally. Zoledronic Acid will be administrated by infusion (IV).~Trial based on a dose escalating study design assessing two dose levels of sirolimus when prescribed in combination with metronomic cyclophosphamide (CP), methotrexate (MT) and zoledronic acid (ZA) followed by an expansion cohort once the MTD is established.
Study NCT04156841 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: mapping agent
Description: according to different tracer methods, patients are divided into the implementation of a single mapping agent and implementation of combination of blue dye and radiotracer agent.
Study NCT04156841 — intervention group
Intervention type: PROCEDURE
Intervention: neoadjuvant chemotherapy
Description: Patients were divided into two groups based on whether they were receiving neoadjuvant chemotherapy.
Study NCT00601224 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social cognition and interaction training (SCIT)
Description: SCIT is a group-based treatment that has the goal of improving social cognition and social functioning for individuals with psychotic disorders. SCIT is composed of three phases: emotion training, figuring out situations, and integration. SCIT will be delivered by two therapists in 20 weekly sessions over 5 months.
Study NCT00601224 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as usual (TAU)
Description: TAU will involve routine care and meeting with case-managers and healthcare providers on an as-needed basis.
Study NCT00601224 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual (TAU)
Description: TAU will involve routine care and meeting with case-managers and healthcare providers on an as-needed basis.
Study NCT02838927 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT00871299 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Cognitive Therapy
Description: Mindfulness-Based Cognitive Therapy (MBCT) is a group treatment that integrates mindfulness meditation training with some CBT concepts and was specifically developed as a relapse prevention intervention for MDD. The program teaches skills that allow patients to disengage from habitual (automatic) dysfunctional cognitive routines, in particular depression-related ruminative thought patterns, as a way to reduce future risk of relapse and recurrence of depression.
Study NCT00871299 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Enhancement Program and medication management
Description: The Health Enhancement Program (HEP)was developed at the University of Wisconsin, Madison and is modeled after traditional activity and nutrition programs used in weight management- cardiac rehab and diabetes prevention programs. The program is designed to increase overall health and well-being by focusing on four health domains that impact health and are interventions regularly practiced at integrative medicine. These include: (I) Music Therapy (2) Nutrition (3) physical activity including, walking and stretching and (4) Functional movement.
Study NCT03590405 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: uterus transplantation surgery and IVF
Description: IVF before surgery living donor uterus transplantation ET
Study NCT03636074 — intervention group
Intervention type: PROCEDURE
Intervention: Hypothermia during Extracorporeal Circulation
Description: Normothermia during Extracorporeal Circulation
Study NCT03260946 — intervention group
Intervention type: OTHER
Intervention: Complementary medicine use
Description: The prevalence of complementary medicine use
Study NCT02064673 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Curcumin
Description: Curcumin or placebo 500mg by mouth twice a day for 6 months
Study NCT02064673 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Curcumin
Description: Curcumin or placebo 500mg by mouth twice a day for 6 months
Study NCT02064673 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Description: placebo orally twice a day
Study NCT02064673 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo orally twice a day
Study NCT04251052 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bilateral Salpingectomy
Description: Undergo bilateral salpingectomy
Study NCT04251052 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bilateral Salpingectomy with Oophorectomy
Description: Undergo bilateral salpingo-oophorectomy
Study NCT04251052 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT04251052 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT01850732 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Ultrasound of aorta
Study NCT01572376 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Infusion of autologous bone marrow stem cells after wound debridement.
Description: Cleaning of the wound with heparinized saline, cell infusion and closing with suture.
Study NCT04279392 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zoledronic Acid 5 mg/Bag 100 ml Inj
Description: Zoledronic acid infusion
Study NCT04279392 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: Saline infusion
Study NCT01164644 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Arnica montana
Description: Subjects will take twelve pills by mouth three times a day over four days.
Study NCT01164644 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will take twelve pills by mouth three times a day over four days.
Study NCT01236365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Description: 10 or 20 mg daily
Study NCT01236365 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Atorvastatin Placebo
Description: 10 or 20 mg daily
Study NCT00602940 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: 12 treatments over 8 weeks
Study NCT00602940 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham Acupuncture
Description: 12 treatments over 8 weeks
Study NCT02708264 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cervical pessary
Description: The cervical pessary is a silicone device that has been used to prevent SPTB
Study NCT00641329 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CLONICEL (clonidine HCl sustained release)
Description: Flexible Dose (0.1 - 0.4 mg)
Study NCT00641329 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo tablets
Study NCT02190045 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wii-Fit exercises
Description: Wii-Fit exercises will be administered for 45 minutes 3 days of the week for 8 weeks
Study NCT02190045 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Cognitive remediation exercises
Description: Cognitive Remediation exercises will be administered for 45 minutes 3 days of the week for 8 weeks
Study NCT03862001 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LungCARE
Description: The LungCARE intervention involves patient and PCP components. The patient component consists of watching a short, educational video, answering questions about lung cancer screening preferences, and receiving a patient report and handout.~The PCP component consists of receiving a similar report (physician report) prior to the patient visit. This report is based on the patient's risk factors and lung cancer screening preferences. It contains additional information about documenting discussions related to risk, screening, and referrals in the electronic medical record system.
Study NCT00700258 — intervention group
Intervention type: DRUG
Intervention: Temsirolimus
Description: Non-interventional study. Treatment decision already made before inclusion into the registry.
Study NCT00700258 — intervention group
Intervention type: DRUG
Intervention: Sunitinib
Description: Non-interventional study. Treatment decision already made before inclusion into the registry.
Study NCT00700258 — intervention group
Intervention type: DRUG
Intervention: Axitinib
Description: Non-interventional study. Treatment decision already made before inclusion into the registry.
Study NCT03237039 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: X-ray examination
Description: Radiological examination of frontal and lateral planes, simultaneously acquired with low dose X-ray system (EOS system, France) in one single exposition. The evaluation of the radiographic images will be performed by an orthopedic physician.Image processing will be performed by a biomedical engineer through sterEOS proprietary software and will provide the anatomical parameters needed to classify the sagittal profile.
Study NCT03237039 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: fall-risk assessment
Description: This evaluation will be performed after the radiographic scan, in the same day. The fall-risk assessment test will be performed by a biomedical engineer through OAK device (OAK, Khymeia, Italy). The OAK device integrates two force plates and sensory elastic straps applied to pelvis and limbs. This test, which takes approximately twenty minutes, accounts eight consecutive postural equilibrium exercises and provide the automatic detection of subject's postural parameters. At the end of the test, the fall-risk rating is automatically assigned.
Study NCT03237039 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: gait cycle analysis
Description: This assessment will be performed in the same session of fall-risk evaluation. The gait cycle analysis, which takes approximately forty minutes, will be executed by a biomedical engineer. Adhesive passive reflective markers will be placed on the skin according to a protocol suitable to characterize the alignment of lower limbs and trunk. The markers trajectories during walk will be recorded by an eight cameras optoelectronic system (BTS smart-D, Italy). A force platform (Kistler, Switzerland) placed in the middle of the pathway will detect the forces exchanged with the ground. The data analysis will provide the kinematic and kinetic descriptive parameters of gait cycle.
Study NCT03925545 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FluidVision AIOL
Description: Investigational implantable medical device intended for long-term use over the lifetime of the cataract subject
Study NCT03925545 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AcrySof IQ monofocal IOL
Description: Commercially available implantable medical device intended for long-term use over the lifetime of the cataract subject
Study NCT03925545 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cataract surgery
Description: Standard cataract extraction with phacoemulsification
Study NCT01147601 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: topical 0.5% Timolol
Description: topical 0.5% Timolol aqueous solution, 2-3 drops to cover the hemangioma, twice daily
Study NCT01147601 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Control (placebo) group
Description: Control (placebo) group
Study NCT04073459 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DTwP-HepB-Sabin IPV-Hib
Description: Intramuscular injection into the anterolateral area of the thigh
Study NCT04073459 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Pentavalent vaccine and Salk IPV
Description: Intramuscular injection into anterolateral area of the thigh
Study NCT03615937 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Child interactive intervention
Description: The Child Interactive Intervention will be delivered through a Dialogic Reading Program, which is an individual/group level intervention component for both families and kindergartens. The original Dialogic Reading Program aims to enhance children's literacy and oral language skills by using the specific technique of shared book reading developed by Whitehurst and colleagues (1988). However, this project will expand from the original Dialogic Reading Program template to include alignment with local kindergarten curriculum and themed interactive activities that help build social competence and emotional maturity in children, in addition to cognitive skills.
Study NCT03615937 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Empowerment
Description: Family empowerment in this project can be conceptualized across three main pillars: 1) adaptive parenting; 2) adaptive extended family environment; and 3) familial resources. Typically, adaptive parenting is translated into positive parenting programs for primary caregivers, and the rest of the family environment involves extended caregivers. However, families from disadvantaged environments encounter many hurdles that hinder effective parenting and relationship nurturing, and parents' mental wellbeing are also consistently impacted by competing demands.
Study NCT03615937 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Access to Community Hub and its services
Description: A new model of Community Hub will be implemented and there will be two hubs established in two respective districts. The Community Hubs act as an alternative venue to implement service delivery of intervention packages, such as activity sessions in the Child Interactive Intervention, Parenting Program, and mentor-mentee experience exchange, which provide families institutional flexibility and extended support while internalizing new practices. There will also be health education, consultation support and developmental assessments. The Hubs will play the roles of promoting and interweaving play-based learning into the lives of families frequently faced with competing demands and a lack of resources, and enable a protracted network for parents.